CervoMed
Boston
About CervoMed
CervoMed is a clinical-stage firm devoted to the research and commercialization of therapeutic treatments for neurodegenerative illnesses, with an emphasis on the early phases of the disease's progression.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $149.4M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2024)
- Ticker: nasdaq:CRVO
- Website: cervomed.com
- Phone: (617) 744-4400
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cervomed-114404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.